Peter Revill

7PUBLICATIONS
27CO-AUTHORS
Medical virologyHaematologyMedical molecular engineering of nucleic acids and proteinsPreventative health careRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2024
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.

Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi

|May 01, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first step.

Jessica Howell, Chris Seaman, Jack Wallace

|Feb 14, 2023
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply.

Josef Wagner, Margaret Littlejohn, Peter A Revill

|Nov 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.

Josef Wagner, Lilly Yuen, Margaret Littlejohn

|Nov 24, 2022
Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.

Jack Wallace, Jacqueline Richmond, Jessica Howell

|Jul 20, 2022
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.

Anna Kramvis, Kyong-Mi Chang, Maura Dandri

Pageof 2

Frequent Collaborators

2 joint publications

Jack Wallace

2 joint publications

Jessica Howell

1 joint publications

Kyong-Mi Chang

1 joint publications

Dieter Glebe